🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study aims to assess the potential benefit and evaluate the safety and ...
Status
Terminated
Location
Research Site
Start Date
2020-08-28
Trial ID
NCT04526912
This is a parallel, Phase 2, 2-arm, double-blind, randomized, multicenter, ...
Status
Terminated
Location
Medical Dermatology Specialists Site Number : 8400002
Start Date
2023-11-01
Trial ID
NCT06118099
Treatments Being Tested
To assess the effects of treatment with XOMA 052 on beta-cell function and ...
Status
Completed
Location
University Hospital Basel
Start Date
2009-09
Trial ID
NCT01788033
The primary objective of this study is to determine the efficacy of phospha...
Status
Terminated
Location
Cleveland Clinic Foundation
Start Date
2009-02
Trial ID
NCT00851747
Treatments Being Tested
To evaluate the safety and tolerability of single dose of SYH2082 Injection...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Nanjing University Medical School
Start Date
2026-04-13
Trial ID
NCT07736404
Treatments Being Tested
This study is a multi-center, randomized, double-blind, placebo-controlled ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-13
Trial ID
NCT06547333
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Active Not Recruiting
Location
Shanghai Dermatology Hospital
Start Date
2024-09-23
Trial ID
NCT06554847
Treatments Being Tested
This is a Phase I/II study designed to evaluate the safety, tolerability, P...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2026-02-05
Trial ID
NCT07375758
Treatments Being Tested
The purpose of this study is to characterize the effects of 85 days treatme...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05-20
Trial ID
NCT02410499
Treatments Being Tested
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01225393
Treatments Being Tested